DOI QR코드

DOI QR Code

Anti-epilepsy Effect of Methanol Extract of Morinda officinalis Augments Pentylenetetrazol-Induced Convulsion Behaviors

파극천 추출물이 펜틸렌테트라졸로 유도된 실험동물에서 항 뇌전증 작용

  • Received : 2012.08.13
  • Accepted : 2013.01.22
  • Published : 2013.02.28

Abstract

Morinda officinalis (MO) is a oriental medicinal herb which has been used traditionally for the treatment of impotence, anti-inflammatory, menstrual irregularity action and various brain diseases including antidepressant and anti-stress. In order to examine the mechanism of anticonvulsive effect, we treated the methanol extract of MO (100, 200 mg/kg, P.0) to the sleeping time and pentylenetetrazol (PTZ)-induced convulsive mice. The methanol extract of MO prolonged sleep time by pentobarbital. Dose-dependent of methanol extracts of MO were effected the concentration of GABA and GABA-T activity in the brain of PTZ-induced mice. Methanol extracts of MO significantly inhibited the convulsion state as well as the level of lipid peroxidation in the brain. The butanol and dichloromethane fraction of methanol extracts among the others effectively inhibited in vitro lipid peroxidation dose dependently ($5.0{\times}10^{-2}{\sim}20.0{\times}10^{-2}g/ml$).

본 연구에서는 파극천 추출물의 수면연장 시간, 항 경련효과 및 시험관내에서 파극천의 각 분획별 활성산소의 소거능을 관찰하여 본 결과 pentobarbital을 투여한 대조군의 수면 유도시간 및 수면시간($3.77{\pm}0.56$분, 수면시간 $68.3{\pm}6.8$분)이 파극천 추출물(200 mg/kg)을 전 처리하고 pentobarbital을 투여함으로써 수면유도 시간($3.95{\pm}0.56$분) 및 수면시간($110.4{\pm}10.3$분)이 연장되었다. PTZ에 의해 유도되는 경련 발작이 대조군 $4.9{\pm}0.98$인데 비해 파극천(200 mg/kg)의 전처리로 경련박작이 $3.2{\pm}0.54$로 현저히 억제되었으며 이 결과는 PTZ의 경련발현시간, 경련유지시간 및 사망시간에 미치는 파극천의 영향과 유사하였다. 뇌중 GABA 함량은 PTZ의 투여로 정상군에 비하여 억제되던 것이 파극천의 전처리로 증가 되었으며, GABA-T의 활성과 지질과산화의 함량은 PTZ의 투여로 각각 증가되던 것이 파극천 추출물의 투여로 억제되었다. 시험관내에서 PTZ로 유도된 뇌조직중의 hydroxy radical의 생성량은 butanol 및 dichlomethane 분획의 첨가($20{\times}10^{-2}g/ml$)에서 약 35%에서 50%까지 감소하였다.

Keywords

References

  1. Allen, I.C. and R. Griffthis. 1984. Reversed-phase high performance liquid chromatographic method for determination of brain glutamate carboxylase suitable for use in kinetic studies. J. Chromatogr. 336(2):385-391.
  2. Aoki, E., R. Semba, K. Kato and S. Kashiwamata. 1987. Purification of specific antibody against aspartate and immunocytochemical localization of aspartergic neurons in the rat brain. Neuroscience 21(3):755-765. https://doi.org/10.1016/0306-4522(87)90035-2
  3. Baughman, R.W. and C.D. Gilbert. 1981. Aspartate and glutamate as possible neurotransmitters in the visual cortex. J. Neurosci. 1(4):427-439.
  4. Behl, C., J.B. Davis, R. Lesley and D. Schubert. 1994. Hydrogen peroxide mediates amyloid $\beta$ protein toxicity. Cell 77(6):817-827. https://doi.org/10.1016/0092-8674(94)90131-7
  5. Bejma, J. and L.L. Ji. 1999. Aging and acute exercise enhance free radical generation in rat skeletal muscle. J. Appl. Physiol. 87(1):465-470.
  6. Buechter, D.D. 1998. Free radicals and oxygen toxicity. Pharmaceut. Res. (5):253-260.
  7. Callaghan, N. and T. Goggin. 1988. Adjunctive therapy in resistant epilepsy. Epilepsia 29(1):S29-35.
  8. Carney, J.M., C.N. Oliver, R.W. Landum, M.S. Cheng, J.F. Wu and R.A. Floyd. 1991. Reversal of age-related changes in brain protein oxidation decrease in enzyme activity. Proc. Natl. Acad. Sci. 88(9):3633-3636.
  9. Chang, P. and K.H. Lee. 1984. Cytotoxic antileukemic anthraquinones from Morinda parvifolia. Phytochemistry 23(8):1733-1736. https://doi.org/10.1016/S0031-9422(00)83480-9
  10. Cohen, G.M. and M.A. Doherty. 1987. Free radical mediated cell toxicity by redox cycling chemicals. Br. J. Cancer Suppl. 8:46-52.
  11. Coyle, J.T. and P. Puttfarcken. 1993. Oxidative stress, glutamate and neurodegenerative disorders. Science 262(5134):689-695. https://doi.org/10.1126/science.7901908
  12. Cupello, A., S. Larsson, A. Palm and M.V. Rapallino. 1988. A microelectro-phoretic method for the evaluation of GABA transaminase activity. Neurochem. Res. 13(7):601-603. https://doi.org/10.1007/BF00973274
  13. Dulac, O. and M. Arthuis 1984 Open trials with vaproate in epilepsy. Epilepsia 25:S23-31. https://doi.org/10.1111/j.1528-1157.1984.tb05633.x
  14. Elwes, R.D.C., A.L. Johnson, S.D. Shorvon and E.H. Reynolds. 1984. The prognosis for seizure control in newly diagnosed epilepsy. N. Engl. J. Med. 311:944-947. https://doi.org/10.1056/NEJM198410113111503
  15. Fernandez, F., W. Morishita, E. Zuniga, J. Nguyen, M. Blank, R. Malenka and C. Garner. 2007. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10(4):411-413.
  16. Ha, J., D. Lee, C. Young, J. Kim and K. Huh. 1999. Agonistic actitivities to the benzodiazepine receptor by extract of medicinal plants(II). Kor. J. Pharmacog. 30(3): 284-289.
  17. Hall, E.D. and M.J. Braughler, 1888. The role of oxygen radical-induced lipid peroxidation in acute CNS trauma. In Halliwell B. (ed.), Oxygen Radicals in Tissue Injury. FASEB, Bethesda, Maryland, USA. pp. 92-96.
  18. Halliwell, B. 1992. Reactive oxygen species and the central nerve system. J. Neurochem. 59(5):1609-1623. https://doi.org/10.1111/j.1471-4159.1992.tb10990.x
  19. Halliwell, M., C. Gutteridge and O.I. Aruoma. 1987. The deoxyribose method: A simple"test-tube" assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem. 165(1):215-219. https://doi.org/10.1016/0003-2697(87)90222-3
  20. Hiramatsu, T., M. Imoto, T. Koyano and K. Umezawa. 1993. Induction of normal phenotypes if ras-transformed cells by damnacanthal from Morinda cirifolia. Cancer Lett. 73(3): 161-166. https://doi.org/10.1016/0304-3835(93)90259-C
  21. Ji, H.J. and S.I. Lee. 1989. Handbook of the Korean Pharmacopoenia. Korean Medical Index. Shinilbooks, Seoul, Korea. p. 494 (in Korean).
  22. Jomova, K. and M. Valko. 2011. Advances in metal-induced oxidative stress and human disease. Toxicology 283(2):65-87. https://doi.org/10.1016/j.tox.2011.03.001
  23. Jung, M., H. Lal and M. Gatch. 2002. The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments. Neurosci. Biobehav. Rev. 26(4):429-439.
  24. Kim, C.M., M.K. Shin, D.K. Ahn and K.S. Lee. 1988. Choongyakdaesajeon. Jongdam publishing Co., Seoul, Korea. pp. 5766-5770 (in Korean).
  25. Kim, H.C. 2004. Hanyakyakrihak. Jipmoondang Publishing Co., Seoul, Korea. pp. 443-445 (in Korean).
  26. Kotama, J., I. Morita, K. Tagahara, O.T. Mukainakab, H. Tokudab and H. Nishinob. 2001. Inhibitory effects of anthraquinones and biaanthraquinones. Epstein-Barr virus activation. Cancer Lett. 170(1):15-18.
  27. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Rendall. 1951. Protein measurement with folin phenol reagent. J. Biol. Chem. 193(1):265-275, 1951.
  28. Martin, T. and L. Hui. 2008. Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis. Chin. Med. J. 121(8):756-761.
  29. Masayuki, Y., Y. Shoko, N. Hiroto, Y. Johji and M. Nobutoshi. 1995. Chemical constituents of Chinese natural medicine, Morindae Radix, the dried roots of Morinda officinalis. Chem. Pharm. Bull. 43(9):1462-1465. https://doi.org/10.1248/cpb.43.1462
  30. Ohkawa, H., N. Ohishi and K. Yaki. 1979. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95(2):351-358. https://doi.org/10.1016/0003-2697(79)90738-3
  31. Roussinov, K.S., M.B. Azarova and S. Atanassova-shopova. 1976. On certain relationships between gamma-aminobutyric acid (GABA) and adrenergic mechanisms in convulsive-seizure reaction. Acta. Physiol. Pharmacol. Bulg. 2(3):69-76.
  32. Sedeghi-Aliabadi, H., T. Tabarzadi and A. Zarghi. 2004. Synthesis and cytotoxic evaluation of two novel anthraquinone derivatives. II Farmaco. 59(8): 645-649. https://doi.org/10.1016/j.farmac.2004.03.006
  33. Stohs, S.J. 1995. The role of free radicals in toxicity and disease. J. Basic Clin. Physiol. Pharmacol. 6(3-4):205-228.
  34. Taloua, J.R., M.C. Verbernea, R.A.B. Muljonoa, L.J.P. Tegelenc, B.G. Bernala, H.J.M. Linthorstb, G.J. Wullemsc, J.F. Bolb and R. Verpoortea. 2001. Isochorismate synthase transgenic expression in Catharanthus roseus cell suspensions. Plant Physiol. Biochem. 39:595-602. https://doi.org/10.1016/S0981-9428(01)01279-7
  35. Valko, M., C.J. Rhodesb, J. Mocola, M. Izakovica and M. Mazura. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (1):1-40. https://doi.org/10.1016/j.cbi.2005.12.009
  36. Vogel, H.G. 2007. Drug discovery and evalution-pharmacological assays. Springer Press. Berlin, Germany. pp. 422-423.
  37. Wolfman, C., H. Viola, M. Marder, C. Wasowski, P. Aedenghi, I. Izquierdo, A.C. Paladini and J.H. Medina. 1996. Anxioselective properties of 6,3-dinitroflavone a high-affinity benzodiazepine receptor ligand. Eur. J. Pharmacol. 318:23-30. https://doi.org/10.1016/S0014-2999(96)00784-4
  38. Zhou, C., Y. Huang and S. Przedborski. 2008. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. NY. Acad. Sci. 1147:93-104. https://doi.org/10.1196/annals.1427.023